Related Experiment Video
Updated: Jun 29, 2025

07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
19.6K
Embracing cancer complexity: Hallmarks of systemic disease
Charles Swanton1, Elsa Bernard2, Chris Abbosh3
1The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cell
|March 29, 2024
Summary
Cancer is a complex systemic disease. Understanding tumor interactions with the body and environmental factors is key to improving cancer prevention and treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Systems Biology
Background:
- The "hallmarks of cancer" framework advanced understanding of carcinogenesis.
- However, molecular mechanisms of systemic effects and cancer mortality causes remain unclear.
- Elucidating tumor-host interactions is vital for cancer prevention and treatment.
Purpose of the Study:
- To discuss cancer as a systemic disease.
- To highlight key factors influencing cancer progression and outcomes.
- To propose future research directions for molecular oncology.
Main Methods:
- Review and synthesis of current knowledge on cancer as a systemic disease.
- Discussion of tumor-host interactions, including microenvironments, aging, metabolism, and the microbiome.
- Emphasis on the need for model systems incorporating human genetic variation.
Main Results:
- Cancer involves complex systemic interactions beyond the primary tumor.
- Factors like aging, metabolism, obesity, cachexia, circadian rhythms, nervous system, thrombosis, and microbiome significantly impact cancer.
- Gene-environment interactions are critical for understanding cancer's systemic nature.
Conclusions:
- A comprehensive understanding of cancer requires viewing it as a systemic disease.
- Future advances depend on integrating molecular oncology with systemic factors.
- Model systems with human genetic variation are essential for deciphering cancer mechanisms and improving patient outcomes.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
What is Cancer?
10.7K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K

